Low dose interferon alfa-2b for chronic hepatitis B in Asian countries
- PMID: 8314500
- PMCID: PMC1374023
- DOI: 10.1136/gut.34.2_suppl.s99
Low dose interferon alfa-2b for chronic hepatitis B in Asian countries
Abstract
In a study of low dose interferon alfa-2b in 587 patients expected to show a good response to treatment, 76-87% patients in different countries had alanine amino-transferase activities returned to normal after four months' treatment, 49-72% were negative for hepatitis B virus (HBV)-DNA, 51-66% were negative for hepatitis B e antigen (HBeAg), and 44-62% were anti-HBe positive. These effects were maintained after nine to 12 months' follow up. Side effects were mild, but led to discontinuation of treatment in 12 patients.
Similar articles
-
Interferon treatment of chronic active hepatitis B: effect of a six month treatment regimen.Gut. 1993;34(2 Suppl):S102-3. doi: 10.1136/gut.34.2_suppl.s102. Gut. 1993. PMID: 8314469 Free PMC article.
-
Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.Med J Aust. 1995 Jan 2;162(1):8-11. Med J Aust. 1995. PMID: 7845310 Clinical Trial.
-
A controlled trial of high dose interferon, alone and after prednisone withdrawal, in the treatment of chronic hepatitis B: long term follow up.Gut. 1993;34(2 Suppl):S91-4. doi: 10.1136/gut.34.2_suppl.s91. Gut. 1993. PMID: 8314497 Free PMC article. Clinical Trial.
-
Treatment of chronic anti-HBe-positive hepatitis B with interferon-alpha.J Hepatol. 1995;22(1 Suppl):42-4. J Hepatol. 1995. PMID: 7602075 Review.
-
Does corticosteroid pretreatment enhance the effect of alfa interferon treatment in chronic hepatitis B?J Hepatol. 1994 Feb;20(2):159-62. doi: 10.1016/s0168-8278(05)80052-2. J Hepatol. 1994. PMID: 8006394 Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical